GlassScriptPhysician profile
Keith Alan Hewitt
NPI 1508834664
$4,713.64
in general payments reported to CMS, 2019-2025
35 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $355 · 2021: $929 · 2022: $923 · 2023: $1,101 · 2024: $421 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,789 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.72 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $997.61 | 2019-2024 | |
| Exeltis, USA INC. | $782.38 | 2020-2025 | Slynd |
| Novo Nordisk INC | $322.54 | 2021-2024 | Wegovy |
| Astellas Pharma US INC | $286.13 | 2019-2025 | Veozah |
| Allergan, INC. | $251.72 | 2019-2020 | |
| Pfizer INC. | $245.95 | 2019-2025 | |
| Hologic Sales and Service, LLC | $193.74 | 2019-2025 | Aptima, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Organon LLC | $183.06 | 2021-2024 | Nexplanon |
| Daiichi Sankyo INC. | $164.07 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $159.17 | 2021-2025 | |
| Aspira Women'S Health INC | $154.98 | 2023-2024 | Ova1 |
| Channel Medsystems, INC. | $150.00 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.85 | 2019-2022 | |
| Biogen, INC. | $89.50 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $46.23 | 2023-2025 | Myfembree |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $45.95 | 2021-2023 | Axonics |
| Avion Pharmaceuticals | $45.44 | 2020-2023 | Balcoltra |
| Millicent US INC | $44.26 | 2023-2024 | Intrarosa, Femring |
| Duchesnay USA Incorporated | $41.96 | 2019 | |
| Baxter Healthcare | $38.32 | 2025 | Perclot, Tisseel |
| Amgen INC. | $37.51 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.16 | 2020-2021 | |
| Therapeuticsmd, INC. | $28.73 | 2021-2022 | |
| Aspen Surgical Products, INC. | $27.73 | 2023 | |
| Roche Diagnostics Corporation | $24.66 | 2019 | |
| Meditrina | $23.01 | 2023 | |
| Ethicon US, LLC | $22.44 | 2025 | Ethicon |
| Caldera Medical, INC | $20.85 | 2023 | Desara |
| Coopersurgical, INC. | $19.50 | 2019 | |
| Shield Therapeutics INC | $18.31 | 2024 | |
| Becton, Dickinson and Company | $18.29 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.37 | 2019 | |
| Lilly USA, LLC | $12.86 | 2020 | |
| Vertical Pharmaceuticals, LLC | $12.24 | 2019 | |
| Sage Therapeutics, LLC | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Hewitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.